Clinical trials
Recruiting Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 3 |
| 2024 | 8 |
| 2025 | 8 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Arrowhead Pharmaceuticals | 2 |
| CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2 |
| Verve Therapeutics, Inc. | 2 |
| Abu Dhabi Health Services Company | 1 |
| Atlantic Health System | 1 |
| Brigham and Women's Hospital | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Children's Hospital of Fudan University | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 32 |
| Hypercholesterolemia | 6 |
| Homozygous Familial Hypercholesterolemia | 5 |
| Cardiovascular Diseases | 4 |
| Dyslipidemias | 4 |
| Hyperlipidemias | 4 |
| Aortic Valve Stenosis | 3 |
| Atherosclerosis | 3 |
| Genetic Diseases, Inborn | 3 |
| Coronary Artery Disease | 2 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.